Rojas_Manual de retina

107

Capítulo 23 Tratamiento de la retinopatía diabética

Bibliografía consultada

SII Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema. The Diabetic Retinopathy Cli nical Research Network. N Engl J Med. 2015 March 26; 372(13):1193-1203. Arevalo JF, Lasave AF, Wu L, Maia M, Diaz-Llopis M, Alezzandrini AA. Intravitreal bevacizumab for pro liferative diabetic retinopathy: Results from the Pan-American collaborative retina study group (PACORES) at 24 Months of Follow-up. Retina. 2017 Feb;37(2):334-43. Boyer DS, Yoon YH, Belfort R Jr., Bandello F, Maturi RK, Augusti AJ, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular ede ma. Ophthalmology. 2014;121:1904-14. Bressler SB, Almukhtar T, Aiello LP, Bressler NM, Ferris FL 3rd, Glassman AR. Green or yellow laser treat ment for diabetic macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research network. Retina. 2013 Nov-Dec;2080-8. Callanan DG, Gupta S, Boyer DS, Ciulla TA, Singer MA, Kuppermann BD, et al. Dexamethasone intra vitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology. 2013;120:1843-51. Campochiaro PA, Brown DM, Pearson A, Ciulla T, Boyer D, Holz FG, et al. Long-term benefit of sustai ned-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology. 2011; 118:626-35.e2. Diabetic Retinophathy Clinical Research Network Writing Comitee on behalf of the DRCR.net. Vitrec tomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117:1087-93. DoDV, NguyenQD, Boyer D, Schmidt U, BrownDM, Vitti R, et al. One-year outcomes of theda Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology. 2012 Aug;119(8):1658-65. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or de ferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117:1064-77. Elman MJ, et al. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibi zumab plus prompt or deferred laser from triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-1077. Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and eficacy of ranibizu mab in diabetic macular edema (RESOLVE study): a 12-month randomized, contolled, double-mas ked, multicenter phase II study: Diabetes Care. 2010 Nov;33(11):2399-2405. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-25. Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, et al. RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials; RISE and RIDE Ophthalmology. 2012 Apr;119:789-801. Pearson PA, Comstock TL, Ip M, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology. 2011;118:1580-87. Schmith-Erfurth. Efficacy and safety of intravitreal afli-bercept in DME. Results of two phase III studies (VIVID-DME and VISTA-DME) EURETINA12th Congress. September 2013. Sivaprasad S, Crosby-Nwaobi R, Heng LZ, Peto T, Michaelides M, Hykin P, et al. Injection frequency and response to bevacizumabmonotherapy for diabetic macular oedema (BOLT Report5). Br J Ophthal mol. 2013 Sep;97(9):1177-80. Yang Y, Bailey C, Loewenstein A, Massin P. Intravitreal corticosteroids in diabetic macular edema: phar macokinetic considerations. Retina 2015 Dec;35(12):2440-9. Lecturas adicionales y otras referencias bibliográficas disponibles en los recursos en línea. SAMPLE